All Stories

  1. Study protocol for a randomized clinical pilot trial investigating feasibility and efficacy of augmenting a virtual reality-assisted intervention targeting auditory verbal hallucinations with biofeedback: The Neuro-VR study
  2. Whole-brain functional connectivity predicts ultra-high risk for psychosis status and level of functioning
  3. Resting-state electroencephalography microstates in antipsychotic-naïve individuals across the psychosis spectrum
  4. Structural covariance network topology in individuals at clinical high risk for psychosis: the ENIGMA-CHR Study
  5. Alleviating negative symptoms in schizophrenia using a virtual reality-based therapy targeting social reward learning (ENGAGE): Protocol for a randomised, controlled, assessor-blind pilot study
  6. Study protocol for a randomized clinical pilot trial investigating feasibility and efficacy of augmenting a virtual reality-assisted intervention targeting auditory verbal hallucinations with biofeedback: the Neuro-VR study
  7. Alleviating negative symptoms in schizophrenia using a Virtual Reality-based therapy targeting social reward learning (ENGAGE): Protocol for a randomised, controlled, assessor-blind pilot study
  8. Cognitive profiles across the psychosis continuum
  9. Publisher Correction: Structural and functional connectivity in relation to executive functions in antipsychotic-naïve patients with first episode schizophrenia
  10. Structural and functional connectivity in relation to executive functions in antipsychotic-naïve patients with first episode schizophrenia
  11. Using brain structural neuroimaging measures to predict psychosis onset for individuals at clinical high-risk
  12. Normative Modeling of Brain Morphometry in Clinical High Risk for Psychosis
  13. Brief rapport: Perceptual aberration in patients at ultra‐high risk for psychosis
  14. Associations between saliva alpha-amylase, heart rate variability, saliva cortisol and cognitive performance in individuals at ultra high-risk for psychosis
  15. Fibre density and fibre-bundle cross-section of the corticospinal tract are distinctly linked to psychosis-specific symptoms in antipsychotic-naïve patients with first-episode schizophrenia
  16. A longitudinal study on physiological stress in individuals at ultra high-risk of psychosis
  17. Sleep disturbances and the association with attenuated psychotic symptoms in individuals at ultra high-risk of psychosis
  18. Premorbid functioning in adolescence associates with comorbid disorders in individuals at ultra‐high risk for psychosis: A brief report
  19. Normative modeling of brain morphometry in Clinical High-Risk for Psychosis
  20. White matter microstructure and sleep-wake disturbances in individuals at ultra-high risk of psychosis
  21. Premorbid adjustment associates with cognitive and functional deficits in individuals at ultra-high risk of psychosis
  22. Neuroanatomical heterogeneity and homogeneity in individuals at clinical high risk for psychosis
  23. Cortico-cognition Coupling in Treatment Resistant Schizophrenia
  24. Differential Effects of Aripiprazole and Amisulpride on Negative and Cognitive Symptoms in Patients With First-Episode Psychoses
  25. Changes in negative symptoms are linked to white matter changes in superior longitudinal fasciculus in individuals at ultra-high risk for psychosis
  26. Global fractional anisotropy predicts transition to psychosis after 12 months in individuals at ultra‐high risk for psychosis
  27. Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis
  28. Thinner cortex is associated with psychosis onset in individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group mega-analysis
  29. Self-perceived cognitive impairments in psychosis ultra-high risk individuals: associations with objective cognitive deficits and functioning
  30. Effectiveness of cognitive remediation in the ultra‐high risk state for psychosis
  31. No Effects of Cognitive Remediation on Cerebral White Matter in Individuals at Ultra-High Risk for Psychosis—A Randomized Clinical Trial
  32. Cognitive remediation plus standard treatment versus standard treatment alone for individuals at ultra-high risk of developing psychosis: Results of the FOCUS randomised clinical trial
  33. Cerebral Glutamate and Gamma-Aminobutyric Acid Levels in Individuals at Ultra-high Risk for Psychosis and the Association With Clinical Symptoms and Cognition
  34. Experiential negative symptoms are more predictive of real-life functional outcome than expressive negative symptoms in clinical high-risk states
  35. The 2019 Schizophrenia International Research Society Conference, 10–14 April, Orlando, Florida: A summary of topics and trends
  36. Predictors of remission from the ultra‐high risk state for psychosis
  37. Assessing social skills in individuals at ultra-high risk for psychosis: Validation of the High Risk Social Challenge task (HiSoC)
  38. Investigating Cognitive and Clinical Predictors of Real-Life Functioning, Functional Capacity, and Quality of Life in Individuals at Ultra-High Risk for Psychosis
  39. Baseline measures of cerebral glutamate and GABA levels in individuals at ultrahigh risk for psychosis: Implications for clinical outcome after 12 months
  40. Development of Executive Functions as Reflected in Daily Life Behaviors in Young Adults at Ultra-High Risk for Psychosis: Associations With Symptoms and Functioning
  41. Basic symptoms influence real‐life functioning and symptoms in individuals at high risk for psychosis
  42. Widespread higher fractional anisotropy associates to better cognitive functions in individuals at ultra‐high risk for psychosis
  43. Emotion recognition latency, but not accuracy, relates to real life functioning in individuals at ultra-high risk for psychosis
  44. Non-pharmacological modulation of cerebral white matter organization: A systematic review of non-psychiatric and psychiatric studies
  45. T16. GLUTAMATERGIC CHANGES IN UHR
  46. Examining speed of processing of facial emotion recognition in individuals at ultra-high risk for psychosis: Associations with symptoms and cognition
  47. The effect of cognitive remediation in individuals at ultra-high risk for psychosis: a systematic review
  48. Negative symptoms mediate the relationship between neurocognition and function in individuals at ultrahigh risk for psychosis
  49. Social cognition in patients at ultra-high risk for psychosis: What is the relation to social skills and functioning?